1-225381539-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001367479.1(DNAH14):​c.13037T>G​(p.Phe4346Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.63 in 1,538,778 control chromosomes in the GnomAD database, including 313,741 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 25900 hom., cov: 32)
Exomes 𝑓: 0.64 ( 287841 hom. )

Consequence

DNAH14
NM_001367479.1 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.88

Publications

24 publications found
Variant links:
Genes affected
DNAH14 (HGNC:2945): (dynein axonemal heavy chain 14) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. Two major classes of dyneins, axonemal and cytoplasmic, have been identified. DNAH14 is an axonemal dynein heavy chain (DHC) (Vaughan et al., 1996 [PubMed 8812413]).[supplied by OMIM, Mar 2008]
DNAH14 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.4610508E-6).
BP6
Variant 1-225381539-T-G is Benign according to our data. Variant chr1-225381539-T-G is described in CliVar as Benign. Clinvar id is 402666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-225381539-T-G is described in CliVar as Benign. Clinvar id is 402666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-225381539-T-G is described in CliVar as Benign. Clinvar id is 402666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-225381539-T-G is described in CliVar as Benign. Clinvar id is 402666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-225381539-T-G is described in CliVar as Benign. Clinvar id is 402666.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.749 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH14NM_001367479.1 linkc.13037T>G p.Phe4346Cys missense_variant Exon 81 of 86 ENST00000682510.1 NP_001354408.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH14ENST00000682510.1 linkc.13037T>G p.Phe4346Cys missense_variant Exon 81 of 86 NM_001367479.1 ENSP00000508305.1 A0A804HLD3

Frequencies

GnomAD3 genomes
AF:
0.553
AC:
84032
AN:
151838
Hom.:
25884
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.259
Gnomad AMI
AF:
0.551
Gnomad AMR
AF:
0.712
Gnomad ASJ
AF:
0.706
Gnomad EAS
AF:
0.769
Gnomad SAS
AF:
0.461
Gnomad FIN
AF:
0.693
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.655
Gnomad OTH
AF:
0.602
GnomAD2 exomes
AF:
0.636
AC:
92658
AN:
145582
AF XY:
0.627
show subpopulations
Gnomad AFR exome
AF:
0.255
Gnomad AMR exome
AF:
0.746
Gnomad ASJ exome
AF:
0.706
Gnomad EAS exome
AF:
0.764
Gnomad FIN exome
AF:
0.690
Gnomad NFE exome
AF:
0.653
Gnomad OTH exome
AF:
0.681
GnomAD4 exome
AF:
0.638
AC:
885049
AN:
1386822
Hom.:
287841
Cov.:
37
AF XY:
0.634
AC XY:
433778
AN XY:
684102
show subpopulations
African (AFR)
AF:
0.238
AC:
7290
AN:
30656
American (AMR)
AF:
0.740
AC:
23983
AN:
32422
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
17572
AN:
24920
East Asian (EAS)
AF:
0.782
AC:
27878
AN:
35648
South Asian (SAS)
AF:
0.473
AC:
36423
AN:
77010
European-Finnish (FIN)
AF:
0.690
AC:
33967
AN:
49206
Middle Eastern (MID)
AF:
0.685
AC:
3881
AN:
5664
European-Non Finnish (NFE)
AF:
0.650
AC:
697486
AN:
1073760
Other (OTH)
AF:
0.636
AC:
36569
AN:
57536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14010
28020
42030
56040
70050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18396
36792
55188
73584
91980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.553
AC:
84065
AN:
151956
Hom.:
25900
Cov.:
32
AF XY:
0.557
AC XY:
41358
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.259
AC:
10708
AN:
41404
American (AMR)
AF:
0.712
AC:
10876
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
2449
AN:
3470
East Asian (EAS)
AF:
0.769
AC:
3973
AN:
5168
South Asian (SAS)
AF:
0.462
AC:
2223
AN:
4808
European-Finnish (FIN)
AF:
0.693
AC:
7307
AN:
10540
Middle Eastern (MID)
AF:
0.697
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
0.655
AC:
44538
AN:
67976
Other (OTH)
AF:
0.608
AC:
1285
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1676
3353
5029
6706
8382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.627
Hom.:
118425
Bravo
AF:
0.548
TwinsUK
AF:
0.643
AC:
2384
ALSPAC
AF:
0.656
AC:
2530
ESP6500AA
AF:
0.245
AC:
339
ESP6500EA
AF:
0.657
AC:
2090
ExAC
AF:
0.538
AC:
11275
Asia WGS
AF:
0.589
AC:
2047
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
18
DANN
Benign
0.47
DEOGEN2
Benign
0.030
T;.;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.64
T;T;.
MetaRNN
Benign
0.0000015
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L;.;.
PhyloP100
2.9
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-3.5
D;D;D
REVEL
Benign
0.069
Sift
Benign
0.15
T;D;D
Sift4G
Uncertain
0.0060
D;D;D
Polyphen
0.0
.;B;B
Vest4
0.26
ClinPred
0.015
T
GERP RS
1.2
Varity_R
0.15
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs950210; hg19: chr1-225569241; COSMIC: COSV59894181; API